Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 24.3B | 25.1B | 25.6B | 29.4B |
Cost of revenue | 16.1B | 14.9B | 16.5B | 19.0B |
Gross profit | 8.2B | 10.2B | 9.2B | 10.4B |
Operating expense | ||||
Research & development | — | 235.3M | 220.2M | 250.6M |
Selling general and admin | 6.0B | 3.5B | 2.5B | 3.1B |
Other operating expenses | — | 224.6M | -677.1M | -177.6M |
Operating income | 8.2B | 1.8B | 3.5B | 3.6B |
Non operating interest income | ||||
Income | — | 290.8M | 203.6M | 180.4M |
Expense | — | 721.9M | 712.2M | 814.8M |
Other income expense | — | — | — | — |
Pretax income | 1.8B | -584.7M | 3.0B | 2.2B |
Tax provision | 361.5M | -399.5M | 393.2M | 246.0M |
Net income | 1.4B | -185.1M | 2.6B | 1.9B |
Basic EPS | 33.9 | — | 66 | 53 |
Diluted EPS | 33.9 | — | 57 | 53 |
Basic average shares | — | — | 38.6M | 38.3M |
Diluted average shares | — | — | 44.8M | 38.3M |
EBITDA | 8.2B | 3.0B | 5.6B | 4.8B |
Net income from continuing op. | — | -185.1M | 2.6B | 1.9B |
Minority interests | -97.1M | -11.5M | -45.1M | 83.2M |
Preferred stock dividends | — | — | — | — |